BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 23297371)

  • 1. Aldosterone-specific activation of cardiomyocyte mineralocorticoid receptor in vivo.
    Messaoudi S; Gravez B; Tarjus A; Pelloux V; Ouvrard-Pascaud A; Delcayre C; Samuel J; Launay JM; Sierra-Ramos C; Alvarez de la Rosa D; Clément K; Farman N; Jaisser F
    Hypertension; 2013 Feb; 61(2):361-7. PubMed ID: 23297371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
    Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
    Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.
    Lavall D; Selzer C; Schuster P; Lenski M; Adam O; Schäfers HJ; Böhm M; Laufs U
    J Biol Chem; 2014 Mar; 289(10):6656-6668. PubMed ID: 24469458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid Receptor Blockade Improves Insulin Sensitivity in the Rat Heart and a Possible Molecular Mechanism.
    Wang M; Li Y; Zhou K; Zhang G; Wang Y; Liu T; Zhang Y; Guo A; An Y
    Cell Physiol Biochem; 2016; 39(3):860-70. PubMed ID: 27497962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
    Gravez B; Tarjus A; Jimenez-Canino R; El Moghrabi S; Messaoudi S; Alvarez de la Rosa D; Jaisser F
    PLoS One; 2013; 8(9):e73737. PubMed ID: 24040049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury.
    Ayuzawa N; Nagase M; Ueda K; Nishimoto M; Kawarazaki W; Marumo T; Aiba A; Sakurai T; Shindo T; Fujita T
    Hypertension; 2016 Jan; 67(1):99-106. PubMed ID: 26527051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor overexpression in embryonic stem cell-derived cardiomyocytes increases their beating frequency.
    Le Menuet D; Munier M; Meduri G; Viengchareun S; Lombès M
    Cardiovasc Res; 2010 Aug; 87(3):467-75. PubMed ID: 20299331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes.
    Lee YS; Kim JA; Kim KL; Jang HS; Kim JM; Lee JY; Shin IS; Lee JS; Suh W; Choi JH; Jeon ES; Byun J; Kim DK
    J Korean Med Sci; 2004 Dec; 19(6):805-11. PubMed ID: 15608389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
    Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
    Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of mineralocorticoid and glucocorticoid receptors to the chronotropic and hypertrophic actions of aldosterone in neonatal rat ventricular myocytes.
    Rossier MF; Python M; Maturana AD
    Endocrinology; 2010 Jun; 151(6):2777-87. PubMed ID: 20392829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
    Hermidorff MM; Faria Gde O; Amâncio Gde C; de Assis LV; Isoldi MC
    Biochem Cell Biol; 2015 Feb; 93(1):83-93. PubMed ID: 25488178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Activation of the Alternative Cardiac Promoter of
    Mesquita TR; Auguste G; Falcón D; Ruiz-Hurtado G; Salazar-Enciso R; Sabourin J; Lefebvre F; Viengchareun S; Kobeissy H; Lechène P; Nicolas V; Fernandez-Celis A; Gómez S; Lauton Santos S; Morel E; Rueda A; López-Andrés N; Gómez AM; Lombès M; Benitah JP
    Circ Res; 2018 Mar; 122(7):e49-e61. PubMed ID: 29467196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early aldosterone-regulated genes in cardiomyocytes: clues to cardiac remodeling?
    Fejes-Tóth G; Náray-Fejes-Tóth A
    Endocrinology; 2007 Apr; 148(4):1502-10. PubMed ID: 17234708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rac1 GTPase regulates 11β hydroxysteroid dehydrogenase type 2 and fibrotic remodeling.
    Lavall D; Schuster P; Jacobs N; Kazakov A; Böhm M; Laufs U
    J Biol Chem; 2017 May; 292(18):7542-7553. PubMed ID: 28320863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-induced changes in the cardiac L-type Ca(2+) current can be prevented by antioxidants in vitro and are absent in rats on low salt diet.
    Wagner M; Rudakova E; Volk T
    Pflugers Arch; 2008 Nov; 457(2):339-49. PubMed ID: 18504604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
    Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heart.
    Latouche C; Sainte-Marie Y; Steenman M; Castro Chaves P; Naray-Fejes-Toth A; Fejes-Toth G; Farman N; Jaisser F
    Endocrinology; 2010 Sep; 151(9):4467-76. PubMed ID: 20591974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
    Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
    Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.